Spots Global Cancer Trial Database for autologous, engineered t cells targeting tp53 r175h
Every month we try and update this database with for autologous, engineered t cells targeting tp53 r175h cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| A Study of NT-175 in Adult Subjects With Unresectable, Advanced, and/or Metastatic Solid Tumors That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation | NCT05877599 | Non-small Cell ... Head and Neck S... Colorectal Carc... Pancreatic Aden... Breast Cancer Other Solid Tum... | Autologous, eng... | 18 Years - | Neogene Therapeutics, Inc. |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
